Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | NKX2-1 |
| Upstream (Parents) |
|---|
| (<<) PRRG4 → NKX2-1 |
| (<<) EGF → NKX2-1 |
| (<<) ASRGL1 → NKX2-1 |
| (<<) TPD52 → NKX2-1 |
| (<<) ATP12A → NKX2-1 |
| (<<) CCDC134 → NKX2-1 |
| (<<) LOC100131795///NMNAT2 → NKX2-1 |
| (<<) BMP1 → NKX2-1 |
| (<<) WASF3 → NKX2-1 |
| (<<) GABRB1 → NKX2-1 |
| Downstream (Children) |
|---|
| NKX2-1 → HSD3B1 (>>) |
| NKX2-1 → EGF (>>) |
| NKX2-1 → ASRGL1 (>>) |
| NKX2-1 → ATP12A (>>) |
| NKX2-1 → FASLG (>>) |
| NKX2-1 → CCDC134 (>>) |
| NKX2-1 → MKRN2 (>>) |
| NKX2-1 → ROS1 (>>) |
| NKX2-1 → WASF3 (>>) |
| NKX2-1 → IFNA10 (>>) |
| NKX2-1 → GABRB1 (>>) |
| NKX2-1 → FABP3 (>>) |
